MDM2 and liposarcoma: MDM2 amplification is present in 95% of well-differentiated and dedifferentiated liposarcomas, while benign lipomatous lesions do not show any amplification; thus, evaluating MDM2 status is crucial in the diagnosis of liposarcoma [52,53].